Muun Health has secured a €700k grant from Enterprise Estonia to develop its Smart Patch Platform. The 1M project’s main focus is advancing Muun Health sensor’s bioselective layer to enable real-time hormone measurement from interstitial fluid.
Muun Health is on a mission to advance women’s health by improving access to high-quality, personalised insights through a novel continuous hormone monitoring solution. The company is developing the first wearable for continuous female hormone monitoring (CFM), providing real-time insights into ovulation and reproductive health.
Unlike traditional methods such as urine tests or blood tests, Muun Health’s technology is a small, painless patch worn on the skin that delivers accurate, personalised and actionable data directly to a smartphone.
This enables women to better understand their cycles, identify optimal times for conception, and detect potential hormonal imbalances or reproductive health issues earlier.
The solution is designed to be user-friendly, more reliable than existing options, and adaptable for broader health applications.
Muun Health is committed to making advanced hormone monitoring technology accessible and affordable, helping women achieve their fertility goals while gaining deeper knowledge and control over their health.
Muun Health was named HealthTech of the Year 2025 at the Estonian Startup Awards and also placed Top 3 Newcomer of the Year.
